SCOTTSDALE, Ariz., May 26, 2010 (GLOBE NEWSWIRE) -- Health Enhancement Products, Inc. (OTCBB:HEPI) today announced details of a scientific panel it will host on June 8, 2010 to discuss the latest developments on the cholesterol-lowering effects of their proprietary natural product ProAlgaZyme®.
The event will feature a live panel presentation, conference call and simultaneous webcast. Interested parties can attend in person or view the webcast at http://www.visualwebcaster.com/event.asp?id=69592. Webcast participants will need to register prior to the event. You will have the ability to type in questions via the webcast. For those who want to call in, and listen only, please dial 888-821-9349 and use pass code 890811#. International callers should dial 201-604-5056. If you plan on attending in person, please register with David Sasso at (305) 918-7000 or email at ds@amcapventures.com.
| WHAT: | Health Enhancement Products Scientific Panel Presentation |
| WHO: | Dr. Smiti Gupta, HEPI principal investigator and assistant professor |
| of nutrition and food sciences at Wayne State University. | |
| Dr. Denis Callewaert, HEPI chief science officer and founder of the | |
| Center for Biomedical Research at Oakland University. | |
| Dr. Fazlul Sarkar, professor of pathology at Wayne State School of | |
| Medicine, senior editor of the Molecular Cancer Therapeutics Journal. | |
| WHEN: | Tuesday, June 8, 2010, 12:00 p.m. ET |
| WHERE: | New York Athletic Club |
| City House | |
| 180 Central Park South | |
| New York, NY 10019 | |
| (212) 247-5100 | |
| WEBCAST: | http://www.visualwebcaster.com/event.asp?id=69592 |
About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. (OTCBB:HEPI) is a health & wellness company engaged in the development of a product comprised of pure, all-natural compounds that can be used as a dietary supplement and food additive. The Company's product is ProAlgaZyme(R)(PAZ(TM)), a liquid product drawn from living algae grown in purified water. The water in which the algae are grown is drawn off, filtered and bottled under the trademark ProAlgaZyme(R).
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
For more information, please visit http://www.heponline.com.